Presentation

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Michael Haude

September 21, 2018

REGISTER for free or LOG IN to view this content

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Coronary

Presentation

TCT 2018

DES/BRS/DCB

Up Next

Presentation

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: Andrejs Erglis

September 21, 2018

More slides +

Presentation

TCT-47: Longitudinal Adaption Of High-Risk Patients Surviving Five Years After Successful MitraClip Implantation

Presenter: Eike Tigges

September 21, 2018

Presentation

TCT-59: Outcomes of Catheter-Directed Thrombolysis versus Standard Medical Therapy in Patients Admitted to Intensive Care Units with Submassive Pulmonary Embolism

Presenter: Stephen D'Auria

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.